Sage Prioritizes Zurzuvae For PPD, Ends MDD Effort, Drops Zulresso

Further Strategic Shifts After Recent Cost Cuts

After recent job cuts, Sage revealed additional strategic updates (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Scrip